At the White House, President Trump announced a deal to make weight loss drugs more affordable. Mr. Trump says drug makers Eli Lilly and Novo Nordisk agreed to lower the price of their popular GLP-1 drugs. CBS News medical contributor Dr. Céline Gounder explains who might see those lower prices.
Breakdown
- President Trump announced a deal to make GLP-1 weight loss drugs more affordable, with Eli Lilly and Novo Nordisk agreeing to lower prices.
- The price of Wegovy could drop from $1,350 to $250 per month for eligible patients at high risk of obesity complications. 30s
- Eligibility for lower prices is limited to those with high-risk health conditions; general obesity or overweight status alone does not qualify. 1m 0s
- Compounded versions of these drugs, once legal during shortages, are now considered illegal and are being challenged by drug makers. 3m 6s
- Dr. Gounder stated that while GLP-1 drugs are helpful, they are not a complete solution to the obesity epidemic and broader strategies are needed. 4m 2s